These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10835953)

  • 21. [The detection of the markers of viral hepatitis B in medical personnel by a radioimmunological method].
    Marievskiĭ VF; Leĭbenzon AS
    Vrach Delo; 1990 Oct; (10):106-7. PubMed ID: 2080558
    [No Abstract]   [Full Text] [Related]  

  • 22. [The evolution of immunological markers in acute viral hepatitis B. A study in 177 patients].
    Cano-Domínguez C; Villarreal-Urenda C; Trejo-Ixcapa S
    Gac Med Mex; 1991; 127(5):405-9. PubMed ID: 1790849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatitis B virus infection in the absence of serological markers or with atypical serological patterns].
    Moreno García M
    Rev Clin Esp; 1997 Apr; 197(4):248-58. PubMed ID: 9254401
    [No Abstract]   [Full Text] [Related]  

  • 24. [Progresses in the molecular diagnosis of hepatitis B viral infection].
    Panait M; Oprişan G; Codiţă I
    Bacteriol Virusol Parazitol Epidemiol; 2008; 53(1):5-12. PubMed ID: 19241991
    [No Abstract]   [Full Text] [Related]  

  • 25. [HBe antigen and HBe antibody].
    Arase Y
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():124-8. PubMed ID: 15453300
    [No Abstract]   [Full Text] [Related]  

  • 26. [HBs antigen. HBs antibody].
    Kumada H
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):241-6. PubMed ID: 12442392
    [No Abstract]   [Full Text] [Related]  

  • 27. Detection of markers of hepatitis viral infection in the tissue of bile duct carcinoma.
    Liu HB; Qian ZY; Wang BS; Tong SX
    Chin Med J (Engl); 2008 Jun; 121(12):1143-4. PubMed ID: 18706237
    [No Abstract]   [Full Text] [Related]  

  • 28. Does hepatitis B serology mean infection or immunity?
    Waring L; Reed C
    Aust Fam Physician; 2000 Feb; 29(2):154-5. PubMed ID: 10743271
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of the appropriateness of hepatitis B serology testing prescribed by general practitioners in a selected area of southern Italy.
    Miragliotta G; Santacroce L; Vinci E
    J Eval Clin Pract; 2007 Oct; 13(5):823-5. PubMed ID: 17824880
    [No Abstract]   [Full Text] [Related]  

  • 30. [Viral markers of hepatitis B, C and D and HB vaccination status of a health care team in a rural district of Cameroon].
    Birguel J; Ndong JG; Akhavan S; Moreau G; Sobnangou JJ; Aurenche C; Lunel F; Thibault V; Huraux JM
    Med Trop (Mars); 2011 Apr; 71(2):201-2. PubMed ID: 21695887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible transmission of hepatitis B virus from a health care worker to a patient.
    Commun Dis Rep CDR Wkly; 1996 Aug; 6(33):283, 286. PubMed ID: 8810120
    [No Abstract]   [Full Text] [Related]  

  • 32. Study of relativity between HBV M and HBV DNA in the cases with hepatitis B.
    Meng Q; Liang R; Liu D
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):352-4. PubMed ID: 11471024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel assay for hepatitis B e markers.
    Boxall EH; Peterson S; Diment J; Graham SE; Shirley JA
    J Med Virol; 1997 Jul; 52(3):280-5. PubMed ID: 9210037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral hepatitis in HIV infection.
    Leiner S
    N Engl J Med; 2007 Jul; 357(1):90; author reply 91. PubMed ID: 17615640
    [No Abstract]   [Full Text] [Related]  

  • 35. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
    Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus infection.
    Ortiz A; De Sequera P; Carreño V; Caramelo C
    N Engl J Med; 1998 Apr; 338(18):1311; author reply 1312-3. PubMed ID: 9580248
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunological markers for early diagnosis and foresight of HBV related fulminant hepatitis].
    Onji M
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):498-501. PubMed ID: 12442434
    [No Abstract]   [Full Text] [Related]  

  • 38. Occult hepatitis B is not necessarily an infection.
    Shorbagi A; Bayraktar Y
    J Clin Gastroenterol; 2008 Oct; 42(9):1064-5. PubMed ID: 18431247
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prevalence of markers of hepatitis B infection in the adult population of the district of Coimbra].
    Santos A; Carvalho A; Tomaz J; Rodrigues V; Coxinho L; Bento D; Sá R; Porto A
    Acta Med Port; 2000; 13(4):167-71. PubMed ID: 11155483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A boost to hepatitis B vaccine: no need for boosters.
    Aggarwal R
    Natl Med J India; 2005; 18(6):313-4. PubMed ID: 16483032
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.